We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+10.63%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$931M
AUM Growth
+$123M
(+15%)
Cap. Flow
+$72.8M
Cap. Flow
% of AUM
7.82%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
1,150
New
406
Increased
162
Reduced
179
Closed
401
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$21.9M |
| 2 |
Microsoft
MSFT
|
+$16.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$12.8M |
| 4 |
Starbucks
SBUX
|
+$12.3M |
| 5 |
Procter & Gamble
PG
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$15.7M |
| 2 |
CrowdStrike
CRWD
|
+$9.68M |
| 3 |
Cisco
CSCO
|
+$9.66M |
| 4 |
S&P Global
SPGI
|
+$7.27M |
| 5 |
Stryker
SYK
|
+$6.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Consumer Discretionary | 14.21% |
| 3 | Healthcare | 10.61% |
| 4 | Financials | 9.66% |
| 5 | Consumer Staples | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
AbCellera Biologics
ABCL
$3.73B
| $233K | 0.03% |
36,090
+17,200
| +91% | +$117K |
|
602
Kite Realty
KRG
$5.16B
| $232K | 0.03% |
+10,400
| New | +$214K |
|
603
O-I Glass
OI
$970M
| $231K | 0.02% |
10,810
-6,000
| -36% | -$130K |
|
604
Jazz Pharmaceuticals
JAZZ
$15.8B
| $230K | 0.02% |
1,858
-8,029
| -81% | -$1.08M |
|
605
Arcos Dorados Holdings
ARCO
$1.63B
| $229K | 0.02% |
+22,354
| New | +$191K |
|
606
W&T Offshore
WTI
$592M
| $228K | 0.02% |
59,031
-43,000
| -42% | -$185K |
|
607
Arbor Realty Trust
ABR
$853M
| $228K | 0.02% |
+15,400
| New | +$191K |
|
608
Clearway Energy Class C
CWEN
$6.17B
| $227K | 0.02% |
7,936
+1,500
| +23% | +$45.3K |
|
609
Fiverr
FVRR
$324M
| $226K | 0.02% |
8,697
-11,100
| -56% | -$334K |
|
610
Zentalis Pharmaceuticals
ZNTL
$290M
| $226K | 0.02% |
+8,011
| New | +$192K |
|
611
Oshkosh
OSK
$9.04B
| $226K | 0.02% |
+2,609
| New | +$205K |
|
612
ePlus
PLUS
$2.43B
| $225K | 0.02% |
+4,005
| New | +$197K |
|
613
Sibanye-Stillwater
SBSW
$8.32B
| $224K | 0.02% |
35,908
+21,303
| +146% | +$168K |
|
614
Tilray
TLRY
$553M
| $224K | 0.02% |
14,354
-16,946
| -54% | -$363K |
|
615
QuidelOrtho
QDEL
$769M
| $224K | 0.02% |
+2,700
| New | +$236K |
|
616
G-III Apparel Group
GIII
$1.23B
| $222K | 0.02% |
+11,497
| New | +$198K |
|
617
Sysco
SYY
$38.1B
| $221K | 0.02% |
+2,983
| New | +$221K |
|
618
RTX Corp
RTX
$266B
| $221K | 0.02% |
+2,258
| New | +$221K |
|
619
WEC Energy
WEC
$33.8B
| $221K | 0.02% |
+2,500
| New | +$231K |
|
620
Applied Industrial Technologies
AIT
$11.8B
| $220K | 0.02% |
1,522
-2,983
| -66% | -$398K |
|
621
Laureate Education
LAUR
$5.01B
| $220K | 0.02% |
+18,200
| New | +$218K |
|
622
Gates Industrial Corp
GTES
$6.59B
| $219K | 0.02% |
+16,223
| New | +$210K |
|
623
Banc of California
BANC
$2.95B
| $218K | 0.02% |
18,824
+5,600
| +42% | +$64.6K |
|
624
Amylyx Pharmaceuticals
AMLX
$3.73B
| $217K | 0.02% |
10,050
-6,300
| -39% | -$170K |
|
625
Criteo S.A.
CRTO
$838M
| $216K | 0.02% |
+6,400
| New | +$206K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Bayesian Capital Management held 1,150 positions worth $931M, up 15% from $808M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Bayesian Capital Management deployed $72.8M of net new capital in Q2 2023, opening 406 new positions and adding to 162 existing holdings. Its largest new stake was NVIDIA: 660,000 shares worth $27.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was S&P Global, an estimated $7.27M trimmed.
- Bayesian Capital Management's largest Q2 2023 buy was NVIDIA: 660,000 shares worth $27.9M.
- Bayesian Capital Management added most to Coca-Cola in Q2 2023, an estimated $10.9M increase.
- Bayesian Capital Management's biggest Q2 2023 reduction was S&P Global, cutting an estimated $7.27M.
- Bayesian Capital Management fully exited Tesla in Q2 2023, selling an estimated $15.7M.
- Bayesian Capital Management's ten largest holdings make up 15% of its $931M portfolio in Q2 2023.
- Bayesian Capital Management opened 406 new positions and closed 401 in Q2 2023.
- Bayesian Capital Management's portfolio value rose 15% quarter-over-quarter to $931M.
Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.